Previous 10 | Next 10 |
Progyny, Inc ( NASDAQ: PGNY ) shares have advanced more than 40% since the beginning of January 2021, and the current share price stands around $59. Progyny expects adjusted EBITDA between $70 million to $75 million for the 2021 fiscal year, but even this doesn’t ...
NEW YORK, June 04, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Liv...
Polen Capital is a global independently-owned growth equity boutique, led by an experienced team of investment professionals who are committed to preserving and growing the assets of our clients through a prudent and disciplined long-term investment approach. The Portfolio returned 2....
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, along with RMA of Connecticut, RMA of New York, and Stanford University partnered on the larg...
Welltok Welcomes Maven and Progyny to its Connect Ecosystem Family Maternal Support, Fertility and Family Building Coverage Among Most Requested Wellbeing Benefits PR Newswire DENVER , May 19, 2021 /PRNewswire/ -- Family planning and fertility benefits a...
Progyny, Inc. (PGNY) Q1 2021 Earnings Conference Call May 6, 2021 4:45 PM ET Company Participants James Hart - Vice President, Investor Relations David Schlanger - CEO Mark Livingston - CFO Pete Anevski - President and COO Conference Call Participants Stephanie Davis - SVB Leerink Anne Samuel...
NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Livi...
Progyny (PGNY): Q1 GAAP EPS of $0.15 beats by $0.09.Revenue of $122.13M (+50.7% Y/Y) beats by $0.68M.Press Release For further details see: Progyny EPS beats by $0.09, beats on revenue
Reports Record First Quarter Revenue of $122.1 Million, Reflecting 51% Growth Issues Revenue Guidance of $126.0 to $131.0 Million for the Second Quarter of 2021, Reflecting Growth of 95% to 103% Continues to Demonstrate Leverage in Operating Model Through Increased Profitability NEW...
NEW YORK, April 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended March 31, 2021 after the c...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period ended June 30, 2024 after the close of the market on Tuesday, August 6, 20...
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that it will host its inaugural Investor Day in New York City on Monday, August 12, 2024, from 9:00 A.M. Eastern Time...
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced an expansion of its global offering with the acquisition of Apryl, a Berlin-based fertility benefits platform founded...